Literature DB >> 26808565

Consideration of noninherited maternal Ags as permissible HLA mismatches in cord blood donor selection.

L Powley1,2, C Brown3, A Melis4,5, Y Li6, G Parkes6, C V Navarrete1,2.   

Abstract

In cord blood (CB) transplantation, virtual 6/6 HLA matches, whereby the donor-recipient mismatch is identical to the CB noninherited maternal Ag (NIMA), have similar outcomes to inherited 6/6 matches. In the UK-British Bone Marrow Registry (BBMR), 4707 of the total 21 020 CB donors have the NIMA defined. Retrospective searches of these donors, for 1-3 NIMA matches, identified a virtual 6/6 match for 31.4% of 274 European Caucasoid (EC) and 25.4% of 67 other ethnicity (OE) patients. Patients weighing ⩽50 kg were also evaluated for a single graft with adequate cell dose. In 125 EC patients, 6/6 HLA matches were identified for 24.0% and virtual 6/6 matches were identified for a further 21.6%. The remaining EC patients had a 5/6 (30.4%) or a 4/6 (22.4%) match. In OE patients, 6/6 HLA matches were identified for 9.3% and virtual 6/6 matches were identified for a further 18.7%. The remaining OE patients had a 5/6 (30.2%) or a 4/6 (37.2%) match. Searches were also performed using the 26 735 Bone Marrow Donors Worldwide CB with defined NIMA and yielded comparable increases. Considering NIMA as permissible mismatches in donor selection therefore increased the availability of a 6/6 match in this cohort.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26808565     DOI: 10.1038/bmt.2015.344

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  14 in total

1.  Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.

Authors:  Mary Eapen; John P Klein; Guillermo F Sanz; Stephen Spellman; Annalisa Ruggeri; Claudio Anasetti; Maria Brown; Richard E Champlin; Joan Garcia-Lopez; Gareth Hattersely; Gesine Koegler; Mary J Laughlin; Gerard Michel; Samir K Nabhan; Franklin O Smith; Mary M Horowitz; Eliane Gluckman; Vanderson Rocha
Journal:  Lancet Oncol       Date:  2011-10-06       Impact factor: 41.316

2.  Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.

Authors:  Vanderson Rocha; Stephen Spellman; Mei-Jie Zhang; Annalisa Ruggeri; Duncan Purtill; Colleen Brady; Lee Ann Baxter-Lowe; Etienne Baudoux; Paola Bergamaschi; Robert Chow; Brian Freed; Gesine Koegler; Joanne Kurtzberg; Jerome Larghero; Lucilla Lecchi; Arnon Nagler; Cristina Navarrette; Vinod Prasad; Fabienne Pouthier; Thomas Price; Voravit Ratanatharathorn; Jon J van Rood; Mary M Horowitz; Eliane Gluckman; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-17       Impact factor: 5.742

3.  Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks.

Authors:  Henk G M Van der Zanden; Jon J Van Rood; Machteld Oudshoorn; Jack N A Bakker; Angelo Melis; Anneke Brand; Andromachi Scaradavou; Pablo Rubinstein
Journal:  Biol Blood Marrow Transplant       Date:  2014-07-18       Impact factor: 5.742

4.  Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.

Authors:  Juliet N Barker; Andromachi Scaradavou; Cladd E Stevens
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

5.  Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

Authors:  Jon J van Rood; Fausto R Loberiza; Mei-Jie Zhang; Machteld Oudshoorn; Frans Claas; Mitchell S Cairo; Richard E Champlin; Robert Peter Gale; Olle Ringdén; Jill M Hows; Mary H Horowitz
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

6.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

7.  The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors.

Authors:  W J Burlingham; A P Grailer; D M Heisey; F H Claas; D Norman; T Mohanakumar; D C Brennan; H de Fijter; T van Gelder; J D Pirsch; H W Sollinger; M A Bean
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

8.  Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice.

Authors:  Partha Dutta; Melanie Molitor-Dart; Joseph L Bobadilla; Drew A Roenneburg; Zhen Yan; Jose R Torrealba; William J Burlingham
Journal:  Blood       Date:  2009-08-21       Impact factor: 22.113

9.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

Review 10.  Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.

Authors:  Vanderson Rocha; Eliane Gluckman
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.